Misplaced Pages

Glasgow-Blatchford score

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Medical screening tool to assess internal bleeding Medical diagnostic method
Glasgow-Blatchford score
Purposeneed for blood transfusion due to GI bleeding

The Glasgow-Blatchford bleeding score (GBS) is a screening tool to assess the likelihood that a person with an acute upper gastrointestinal bleeding (UGIB) will need to have medical intervention such as a blood transfusion or endoscopic intervention. The tool may be able to identify people who do not need to be admitted to hospital after a UGIB. Advantages of the GBS over the Rockall score, which assesses the risk of death in UGIB, include a lack of subjective variables such as the severity of systemic diseases and the lack of a need for oesophagogastroduodenoscopy (OGD) to complete the score, a feature unique to the GBS.

It was developed in 2000 by Oliver Blatchford (born 24 August 1954) at the Glasgow Royal Infirmary.

In a controlled study, 16% of people presenting with UGIB had a GBS score of "0", considered low. Among this group there were no deaths or interventions needed and people were able to be effectively treated in an outpatient setting.

Criteria

The score is calculated using the table below:

Admission
risk marker
Score component
value
Blood urea (mmol/L)
6.5–8.0 2
8.0–10.0 3
10.0–25 4
> 25 6
Haemoglobin (g/dL) for men
12.0–12.9 1
10.0–11.9 3
< 10.0 6
Haemoglobin (g/dL) for women
10.0–11.9 1
< 10.0 6
Systolic blood pressure (mm Hg)
100–109 1
90–99 2
< 90 3
Other markers
Pulse ≥ 100/min 1
Melaena 1
Syncope 2
Hepatic disease 2
Cardiac failure 2

In the validation group, scores of 6 or more were associated with a greater than 50% risk of needing an intervention.

Score

Score is equal to "0" if the following are all present:

See also

References

  1. Blatchford, O.; Murray, W. R.; Blatchford, M. (2000). "A risk score to predict need for treatment for uppergastrointestinal haemorrhage". Lancet. 356 (9238): 1318–1321. doi:10.1016/S0140-6736(00)02816-6. PMID 11073021. S2CID 6371737. Retrieved 2009-02-17.
  2. Stanley, A. J.; Ashley, D.; Dalton, H. R.; Mowat, C.; Gaya, D. R.; Thompson, E.; Warshow, U.; Groome, M.; Cahill, A.; Benson, G.; Blatchford, O.; Murray, W. (2009). "Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation". Lancet. 373 (9657): 42–47. doi:10.1016/S0140-6736(08)61769-9. PMID 19091393. S2CID 1738579. Retrieved 2009-01-24.
  3. "Archived copy". Archived from the original on 2014-12-19. Retrieved 2014-12-19.{{cite web}}: CS1 maint: archived copy as title (link)
Diseases of the human digestive system
Upper GI tract
Esophagus
Stomach
Lower GI tract
Enteropathy
Small intestine
(Duodenum/Jejunum/Ileum)
Large intestine
(Appendix/Colon)
Large and/or small
Rectum
Anal canal
GI bleeding
Accessory
Liver
Gallbladder
Bile duct/
Other biliary tree
Pancreatic
Other
Hernia
Peritoneal
Categories: